Related Experiment Videos
[Studies on the physical dependence liability to guanabenz]
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
|November 1, 1982
Summary
Guanabenz, a hypotensive drug, demonstrated analgesic properties but did not cause physical dependence like morphine or barbiturates. While it suppressed withdrawal signs, it did not substitute for these drugs and showed no dependence liability itself.
Area of Science:
- Pharmacology
- Neuroscience
- Drug Dependence
Context:
- Guanabenz is an antihypertensive medication acting as a central noradrenergic alpha 2-agonist.
- Investigating the potential for physical dependence is crucial for understanding drug safety and abuse liability.
Purpose:
- To evaluate the physical dependence liability of guanabenz.
- To assess guanabenz's effects on analgesia, tolerance, and withdrawal symptoms associated with opioid and sedative-hypnotic drugs.
Summary:
- Guanabenz exhibited potent analgesic effects comparable to morphine, with tolerance developing upon repeated administration.
- It potentiated morphine analgesia and prolonged hexobarbital hypnosis.
- Guanabenz suppressed morphine and barbital withdrawal signs but could not substitute for barbital and required high, potentially lethal doses for barbital withdrawal suppression. No withdrawal signs were observed after chronic guanabenz administration.
Impact:
- Guanabenz does not appear to possess physical dependence liability of the morphine or barbital type.
- Findings contribute to the understanding of guanabenz's pharmacological profile and its safety regarding drug dependence.
- This research informs clinical use and potential misuse of guanabenz and similar compounds.